Rare & Orphan Lab · DeCure for X

DeCure for Congenital diarrhea 5 with tufting enteropathy

DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for congenital diarrhea 5 with tufting enteropathy — screening already-approved drugs against its 2-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.

Disease module2 genesLead labRare & Orphan
All cures
Rare & OrphanDOID:0060776$DeCureRare

The disease map

Disease moduleCongenital diarrhea 5 with tufting enteropathy maps to a 2-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.

Research record

01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash

Current lead

No approved-drug candidate for congenital diarrhea 5 with tufting enteropathy is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.

Molecular view

epithelial cell adhesion molecule (EPCAM)EPCAM is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.

Loading structure…
helix sheet dmudrag to rotate · scroll to zoom

RCSB Protein Data Bank · entry 4MZV · 1.865 Å · ligand DECYL-BETA-D-MALTOPYRANOSIDE (DMU). Experimental structure, not a prediction.

What the evidence adds up to

Four children from two consanguineous families presented within the first two weeks of life with intractable diarrhoea, electrolyte disturbance, abdominal distension, and failure to thrive. All required total parenteral nutrition. Small bowel biopsies showed subtotal villous atrophy with crypt hyperplasia and characteristic tufting of surface enterocytes. Two patients died in infancy from intractable diarrhoea and sepsis. The two surviving patients developed morning stiffness, pain, and swelling in multiple joints at around four years of age, with progressive contractures and tenosynovitis. Nonsteroidal anti-inflammatory drugs, prednisone, sulfasalazine, and methotrexate produced a poor response. The addition of etanercept led to resolution of joint pain and swelling and significant improvement in range of motion, allowing weaning off prednisone, methotrexate, and etanercept. Inflammatory markers fell, and bowel habit improved enough that both patients became free of total parenteral nutrition.

A novel homozygous single base pair insertion in exon 5 of EpCAM (c.498insC) was identified in one of the two surviving patients. In two Korean siblings with tufting enteropathy, compound heterozygous mutations were found: a donor splicing site mutation in intron 5 (c.491+1G>A) and a novel nonsense mutation in exon 3 (c.316A>T, Lys106X). The sister had juvenile rheumatoid arthritis. A later case report describes erosive arthritis in congenital tufting enteropathy, a feature not present in earlier cases. A 2023 report of a three-year-old girl with congenital tufting enteropathy due to EPCAM mutation reiterates the need for lifelong total parenteral nutrition or small bowel transplantation in severe cases.

The association between tufting enteropathy and chronic arthritis is documented in only a handful of cases. The mechanism linking EpCAM mutations to late-onset arthritis is unknown. No systematic trial has tested any treatment for the arthritis or the enteropathy. What is missing is a larger case series or registry to define the natural history of the joint disease, molecular data on more patients to test for genotype-phenotype correlations, and any controlled evidence for etanercept or other biologic agents in this population.

Evidence

Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.

Journal of Pediatric Gastroenterology and Nutrition · 2009 · 44 citations

Tufting Enteropathy and Chronic Arthritis: A Newly Recognized Association With a Novel <i>EpCAM</i> Gene Mutation

AbstractIntractable diarrhea of infancy is a descriptive term rather than a specific diagnosis. Patients usually present in the neonatal period with severe intractable watery diarrhea, malabsorption, and failure to thrive. It is etiologically heterogeneous but is often infectious or inflammatory in origin (1). Tufting enteropathy, also known as intestinal epithelial dysplasia, is one of the causes of congenital intractable diarrhea and is characterized by persistent villous atrophy and a pathognomonic histological appearance (1–3). Recently, mutations in the epithelial cell adhesion molecule (EpCAM) gene were identified as the responsible genetic defect in patients with tufting enteropathy (4). The coexistence of intractable diarrhea of infancy and chronic arthritis is rare and has limited possible underlying causes (5,6). To the best of our knowledge, there are no previous reports of chronic arthritis in children with tufting enteropathy. We describe the clinical, biochemical, molecular, and radiological analysis as well as treatment and outcome of 4 children with tufting enteropathy seen at our hospital. METHODS We retrospectively reviewed data of children with tufting enteropathy and chronic arthritis obtained at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Data included demographics, clinical presentation, laboratory parameters, radiological and histopathological features, limited molecular analysis, treatment, disease course, and outcome of these patients. DNA Extraction Genomic DNA was extracted from whole blood anticoagulated with ethylenediaminetetraacidic acid using the Purgene Gentra DNA Extraction Kit (Cat. # D-5000, Gentra Systems, Minneapolis, MN) according to the manufacturer's instructions. The DNA was quantified spectrophotometrically and stored in aliquots at −20°C until required. Polymerase Chain Reaction and Direct Sequencing Polymerase chain reaction amplification was performed on a thermocycler (DNA Engine Tetrad. MJ Research, Inc, Waltham, MA) in a total volume of 25 μL, containing 10 ng DNA, 50 mmol/L KCl, 10 mmol/L Tris-HCl (pH 9.0), 1.5 mmol/L MgCl2, 0.1% Triton X-100, 0.25 mmol/L of each deoxyribonucleotide triphosphate, 0.8 μmol/L of each primer and 0.5 U of Taq polymerase (QIAGEN, D-40724, Hilden, Germany). For polymerase chain reaction, an initial denaturation step at 95°C for 10 minutes was followed by 40 cycles of denaturation at 95°C for 30 seconds, annealing at 59°C for 30 seconds and extension at 72°C for 30 seconds followed by a final extension step of 72°C for 10 minutes. The primers used for amplification of the coding regions of EpCAM are available upon request. Genomic DNA from the patients were screened for mutations in the exons and splice sites of EpCAM by using the BigDye Terminator v3.1 Cycle Sequencing Kit from Applied Biosystems, and samples were loaded onto ABI PRISM 3730XL DNA analyzer system (Applied Biosystems, Foster City, CA), following the manufacturer's instructions. Sequence analysis was performed using the SeqManII module of the Lasergene (DNA Star Inc, Madison, WI) software package, then compared with a reference sequence. RESULTS Four patients (2 males and 2 females) from 2 unrelated families who were referred with infantile intractable diarrhea were found to have tufting enteropathy. The parents of these patients were first cousins and healthy. All patients who presented at the age of 1 to 2 weeks were diagnosed with intractable diarrhea, electrolyte disturbance, abdominal distension, and failure to thrive (growth parameters were significantly below the fifth percentiles). They were fed different formula but did not show any improvement and eventually all required total parenteral nutrition (TPN). There was no dysmorphism noted on examination. The initial laboratory findings showed normal complete blood count and electrolyte disturbance (mainly low sodium, chloride, magnesium, and calcium). Liver function tests were normal, but 1 patient had progressive liver function derangement probably because of TPN. Serum immunoglobulin levels, sweat chloride test, and thyroid function test were normal. Autoimmune screen including antimitochondrial, antismooth muscle, and celiac disease panel were negative. Although 2 patients were weakly positive for anti-nuclear antibody titer, they were negative for extractable nuclear antigens. All cultures including stool culture were negative. Small bowel and colonic biopsies showed subtotal villous atrophy associated with mild crypt hyperplasia. The lamina propria contained a relatively normal number of chronic inflammatory cells. There was no chronic crypt damage or active duodenitis. The intraepithelial lymphocytes were not increased. Interestingly, the luminal enterocytes were closely packed and showed characteristic tufting with rounding of their apical cytoplasm. These findings were consistent with tufting enteropathy (Fig. 1).FIG. 1: Subtotal villous atrophy with crypt hyperplasia and tufting of the epithelial surface.Unfortunately, 2 patients (1 from each family) died in the infancy period because of the intractable diarrhea and sepsis (1 additionally had progressive liver failure secondary to TPN). The other 2 patients are still alive but continue to have intractable diarrhea and failure to thrive. Interestingly, at around 4 years of age, both started to develop morning stiffness, pain, and swelling in multiple joints including the interphalangeal and metacarpophalangeal joints of hands, wrists, and knees. During follow-up it was noticed that both had progressive contractures associated with flexor and extensor tenosynovitis of the hands but no evidence of enthsitis or other associated systemic symptoms. The surviving patients had elevated erythrocyte sedimentation rate and C-reactive protein. Urine and stool cultures were negative. X-ray of affected joints showed generalized osteopenia with increased trabeculation especially at the epiphysis of the metacarpophalangeal joints and carpal bones with synovial hypertrophy but no erosive changes. A novel homozygous single base pair insertion was identified in exon 5 of EpCAM in 1 of the 2 surviving patients (c.498insC). The resulting frameshift introduces 21 novel amino acids followed by premature truncation of the protein (Q167Pfsx21). Nonsteroidal anti-inflammatory drugs, prednisone, sulfasalazine followed by methotrexate were tried but the response was poor. However, the addition of antitumor necrosis factor (Etanercept) resulted in resolution of the joint pain, swelling, and tenosynovitis as well as significant improvement in the range of motion of the affected joints. Fortunately, we were able to wean off prednisone, methotrexate, and etanercept. During follow-up it was noticed that both had inactive arthritis and low inflammatory markers. There has been some improvement in their bowel habit; it became less frequent than before and both were tolerating and continued to be TPN free. DISCUSSION Tufting enteropathy is a rare autosomal recessive form of intractable diarrhea of infancy. Typically, patients develop watery diarrhea within the first days after birth and have the characteristic appearance of subtotal villous atrophy with crypt hyperplasia and tufting of the epithelial surface (7). It is more frequent in patients of Arabic origin probably because of a higher degree of consanguinity (7). Sivagnanam et al (4) identified EpCAM responsible gene for tufting enteropathy. They speculated that EpCAM plays an important role in the normal development of the crypt villus axis, where epithelial cells originate from stem cells in the crypt and migrate distally to the tip of the villous before shedding, so that perturbation of this developmental process may underlie the pathogenesis of tufting enteropathy in patients with EpCAM mutations. Several cases of tufting enteropathy have been reported as being associated with phenotypic abnormalities (8). The association between tufting enteropathy and autoimmune disorders has only been documented in a recent case report that described autoimmune anemia, thrombocytopenia, and skeletal dysplasia but no associated arthritis (9). The 4 patients described in this report have the typical clinical and histological features of tufting enteropathy; 2 of them later developed chronic inflammatory arthritis in multiple joints at the age of 4 years. This previously undescribed observation was not seen in their siblings, but that could be because of their early death in infancy. Both had active arthritis in small and large joints as well as tenosynovitis associated with elevated inflammatory markers, and radiological changes are consistent with chronic arthritic changes. Fortunately, their musculoskeletal symptoms responded well to the intensive therapy. Our patients did not have evidence of systemic disease despite extensive workup, although their autoimmune workup was inconclusive. Of note, bowel biopsy did not show any inflammatory cell infiltrate in the lamina propria, which makes the possibility of autoimmune enteropathy unlikely. The factors responsible for the late initiation and perpetuation of arthritis in our patients are unclear. Although no enteric pathogens were isolated, the possible roles of enteric infection or allergic reactions to food absorbed across an inflamed mucosa remain speculative. Rheumatic manifestations of diseases primarily of the gastrointestinal tract are frequent and variable. These manifestations include arthralgia, transient or chronic arthritis, and osteoporosis. The association of chronic diarrhea and arthritis in early childhood may lead to suspect limited differential diagnoses including inflammatory bowel disease, which is a familial disease that can affect all age groups, although it has not been well described in infants. Patients with inflammatory bowel disease may present with isolated chronic diarrhea but go on to develop arthritis later in life (10,11). Celiac disease is a primary gastrointestinal disease with a wide clinical spectrum that sometimes includes polyarthritis (12). There are rare conditions characterized clinically by chronic diarrhea and nondestructive arthritis. Biopsies from the colorectal mucosa showed a thickened subepithelial collagen layer consistent with collagenous colitis (13). Infantile systemic hyalinosis is a rare inherited disease of connective tissue characterized by widespread deposition of hyaline material in skin, musculoskeletal, and deep organs including the gut in addition to nodule formation and joint contractures. Most of the patients failed to thrive, with severe muscle wasting and intractable diarrhea (6). Juvenile idiopathic arthritis is the most frequent form of chronic arthritis in children. Juvenile idiopathic arthritis rarely occurs as a familial disease, although detailed family studies of patients and first-degree relatives have been published (14). Systemic onset subtype of juvenile idiopathic arthritis may associate with abdominal pain because of peritonitis but never associate with chronic diarrhea. Our clinical observation indicates that patients with tufting enteropathy are prone to develop chronic arthritis, and this report should increase the awareness of this association, especially in older children, and help in the identification of similar cases. Our ability to speculate on a possible genotype-phenotype correlation is limited by the fact that we have molecular data on only 1 of the 2 patients with this apparently novel association. Future clinical reports on tufting enteropathy with mutation information will be necessary to test for such correlations.

https://doi.org/10.1097/mpg.0b013e3181acaeae
Gut and Liver · 2010 · 41 citations · open access

Tufting Enteropathy with EpCAM Mutations in Two Siblings

AbstractTufting enteropathy is a rare autosomal recessive disorder presenting with early-onset severe intractable diarrhea. The epithelial cell adhesion molecule gene (EpCAM) has recently been identified as the gene responsible for tufting enteropathy. Based on histology, a diagnosis of tufting enteropathy was made in two Korean siblings. They developed chronic diarrhea and failure to thrive. They had a broad nasal bridge and micrognathia. Duodenal and colonic biopsies showed villous atrophy, disorganization of surface enterocytes, and focal crowding resembling tufts. Protracted diarrhea continued and so cyclic parenteral nutrition was supplied. The sister had juvenile rheumatoid arthritis. Mutation analysis of EpCAM identified two compound heterozygous mutations in these siblings: 1) a donor splicing site mutation in intron 5 (c.491+1G>A) and 2) a novel nonsense mutation in exon 3 (c.316A>T, Lys106X). Analysis of EpCAM will be useful for genetic counseling and prenatal diagnosis of tufting enteropathy.

https://doi.org/10.5009/gnl.2010.4.3.407
BMJ Case Reports · 2016 · 9 citations

Congenital tufting enteropathy and chronic arthritis: a clinical and radiological perspective

AbstractCongenital tufting enteropathy is a rare condition which presents in early infancy. It is a condition which should be suspected in infants who present with diarrhoea soon after birth. A rare association with arthritis has been observed with a handful of cases documented in the literature. Our case differs as the arthritis described is erosive in nature, a feature which is not present in other cases.

https://doi.org/10.1136/bcr-2016-215252
Case Reports in Pediatrics · 2023 · 1 citations · open access

Congenital Tufting Enteropathy, a Rare Cause of Diarrhea and Malnourishment in Arab Child with Genetic and Histopathology Investigations

AbstractCongenital tufting enteropathy (CTE), also known as intestinal epithelial dysplasia (IED), is a rare autosomal recessive disorder due to EPCAM gene mutation. It is a rare congenital enteropathy that presents in early infancy as an intractable diarrhea that is independent of breast formula feeding that requires life-long total parental nutrition (TPN) to acquire adequate calories and fluid intake or small bowel transplantation in severe cases. Here, we report a case of intestinal failure due to congenital tufting enteropathy in a 3-year-old girl who presented with loose stools and failure to thrive. This study aims to review the literature about CTE and discuss the clinicopathological aspects and to be able to distinguish it from other causes of congenital diarrheal disorders (CDDs).

https://doi.org/10.1155/2023/6301065

Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.

DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.